rs33927012

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_003000.3(SDHB):​c.487T>C​(p.Ser163Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0131 in 1,613,448 control chromosomes in the GnomAD database, including 207 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S163F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0095 ( 14 hom., cov: 32)
Exomes 𝑓: 0.013 ( 193 hom. )

Consequence

SDHB
NM_003000.3 missense

Scores

5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:27O:1

Conservation

PhyloP100: 4.71

Publications

52 publications found
Variant links:
Genes affected
SDHB (HGNC:10681): (succinate dehydrogenase complex iron sulfur subunit B) This tumor suppressor gene encodes the iron-sulfur protein subunit of the succinate dehydrogenase (SDH) enzyme complex which plays a critical role in mitochondria. The SDH enzyme complex is composed of four nuclear-encoded subunits. This enzyme complex converts succinate to fumarate which releases electrons as part of the citric acid cycle, and the enzyme complex additionally provides an attachment site for released electrons to be transferred to the oxidative phosphorylation pathway. The SDH enzyme complex plays a role in oxygen-related gene regulation through its conversion of succinate, which is an oxygen sensor that stabilizes the hypoxia-inducible factor 1 (HIF1) transcription factor. Sporadic and familial mutations in this gene result in paragangliomas, pheochromocytoma, and gastrointestinal stromal tumors, supporting a link between mitochondrial dysfunction and tumorigenesis. Mutations in this gene are also implicated in nuclear type 4 mitochondrial complex II deficiency. [provided by RefSeq, Jun 2022]
SDHB Gene-Disease associations (from GenCC):
  • Carney-Stratakis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • gastrointestinal stromal tumor
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • pheochromocytoma/paraganglioma syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • renal cell carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • mitochondrial complex 2 deficiency, nuclear type 4
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • mitochondrial complex II deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PM1
In a region_of_interest Interaction with SDHAF1 (size 72) in uniprot entity SDHB_HUMAN there are 37 pathogenic changes around while only 2 benign (95%) in NM_003000.3
BP4
Computational evidence support a benign effect (MetaRNN=0.008068502).
BP6
Variant 1-17027802-A-G is Benign according to our data. Variant chr1-17027802-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 12792.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00947 (1441/152204) while in subpopulation SAS AF = 0.0193 (93/4824). AF 95% confidence interval is 0.0161. There are 14 homozygotes in GnomAd4. There are 717 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003000.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SDHB
NM_003000.3
MANE Select
c.487T>Cp.Ser163Pro
missense
Exon 5 of 8NP_002991.2P21912
SDHB
NM_001407361.1
c.433T>Cp.Ser145Pro
missense
Exon 5 of 8NP_001394290.1A0AAQ5BHD9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SDHB
ENST00000375499.8
TSL:1 MANE Select
c.487T>Cp.Ser163Pro
missense
Exon 5 of 8ENSP00000364649.3P21912
SDHB
ENST00000714034.1
c.532T>Cp.Ser178Pro
missense
Exon 6 of 9ENSP00000519325.1A0AAQ5BHC9
SDHB
ENST00000925621.1
c.481T>Cp.Ser161Pro
missense
Exon 5 of 8ENSP00000595680.1

Frequencies

GnomAD3 genomes
AF:
0.00947
AC:
1441
AN:
152086
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00179
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00465
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0191
Gnomad FIN
AF:
0.0185
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0141
Gnomad OTH
AF:
0.00909
GnomAD2 exomes
AF:
0.0121
AC:
3045
AN:
251388
AF XY:
0.0130
show subpopulations
Gnomad AFR exome
AF:
0.00178
Gnomad AMR exome
AF:
0.00393
Gnomad ASJ exome
AF:
0.00655
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0216
Gnomad NFE exome
AF:
0.0152
Gnomad OTH exome
AF:
0.0114
GnomAD4 exome
AF:
0.0135
AC:
19718
AN:
1461244
Hom.:
193
Cov.:
29
AF XY:
0.0137
AC XY:
9927
AN XY:
726966
show subpopulations
African (AFR)
AF:
0.00215
AC:
72
AN:
33474
American (AMR)
AF:
0.00362
AC:
162
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00612
AC:
160
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39692
South Asian (SAS)
AF:
0.0174
AC:
1505
AN:
86248
European-Finnish (FIN)
AF:
0.0215
AC:
1149
AN:
53366
Middle Eastern (MID)
AF:
0.0123
AC:
71
AN:
5768
European-Non Finnish (NFE)
AF:
0.0143
AC:
15925
AN:
1111470
Other (OTH)
AF:
0.0111
AC:
673
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
932
1865
2797
3730
4662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
592
1184
1776
2368
2960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00947
AC:
1441
AN:
152204
Hom.:
14
Cov.:
32
AF XY:
0.00963
AC XY:
717
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.00178
AC:
74
AN:
41552
American (AMR)
AF:
0.00465
AC:
71
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.0193
AC:
93
AN:
4824
European-Finnish (FIN)
AF:
0.0185
AC:
196
AN:
10594
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0141
AC:
960
AN:
67998
Other (OTH)
AF:
0.00852
AC:
18
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
78
156
233
311
389
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0121
Hom.:
54
Bravo
AF:
0.00751
TwinsUK
AF:
0.0183
AC:
68
ALSPAC
AF:
0.0125
AC:
48
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.0130
AC:
112
ExAC
AF:
0.0125
AC:
1523
Asia WGS
AF:
0.00866
AC:
30
AN:
3478
EpiCase
AF:
0.0136
EpiControl
AF:
0.0149

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
11
not specified (12)
-
1
4
not provided (5)
-
2
3
Pheochromocytoma/paraganglioma syndrome 4 (5)
-
-
2
Gastrointestinal stromal tumor (2)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
Hereditary pheochromocytoma and paraganglioma (2)
-
-
1
Carney-Stratakis syndrome (1)
-
1
-
Cowden syndrome (1)
-
-
1
Malignant tumor of breast (1)
-
-
1
Pheochromocytoma;C0238198:Gastrointestinal stromal tumor;C1861848:Pheochromocytoma/paraganglioma syndrome 4 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.085
T
BayesDel_noAF
Uncertain
0.12
CADD
Benign
22
DANN
Benign
0.86
DEOGEN2
Benign
0.24
T
Eigen
Benign
-0.23
Eigen_PC
Benign
0.029
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0081
T
MetaSVM
Uncertain
0.12
D
MutationAssessor
Benign
0.47
N
PhyloP100
4.7
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
0.44
N
REVEL
Uncertain
0.44
Sift
Benign
0.77
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.12
MPC
0.21
ClinPred
0.025
T
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.19
gMVP
0.76
Mutation Taster
=44/56
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33927012; hg19: chr1-17354297; COSMIC: COSV64965186; COSMIC: COSV64965186; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.